Genmab and AbbVie Clarify EPCORE DLBCL-1 Phase 3 Results
COPENHAGEN, Denmark and NORTH CHICAGO, Ill., July 23, 2026 Genmab and AbbVie have issued a clarification regarding the Phase...
Genmab
Advertisement
Genmab Wins EU Approval for TEPKINLY Plus R2
COPENHAGEN, Denmark, July 6, 2026 Genmab A/S announced that the European Commission (EC) has granted marketing authorization for TEPKINLY®...
Genmab Phase 3 Epcoritamab Trial Meets Primary PFS Endpoint
COPENHAGEN, Denmark, June 29, 2026 Genmab A/S announced positive topline results from the Phase 3 EPCORE DLBCL-4 clinical trial...
Genmab Reports Positive EPCORE FL-1 Data for Epcoritamab Combination
COPENHAGEN, Denmark, June 11, 2026 Genmab A/S announced new subgroup analysis results from the pivotal Phase 3 EPCORE FL-1...
Genmab Advances Strategic Expansion with Completion of Merus Tender Offer
COPENHAGEN, Denmark – December 12, 2025 — Genmab has completed its tender offer to acquire outstanding common shares of...
Advertisement
